RAD51D and ovarian cancer: The age at ovarian cancer diagnosis is older for women with mutations in RAD51D, suggesting that it is safe to delay risk-reducing salpingo-oophorectomy (RRSO) until age 45–50 in RAD51D mutation carriers [38].